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Surface plasmon resonanceThere is increasing evidence that soluble glycosaminoglycans such as heparin can interferewith the infectivity of
various viruses, including ecotropic murine leukemia viruses (MLVs). The ecotropic MLV, Friend MLV (F-MLV)
and the neuropathogenic variants A8 MLV and PVC-211 MLV, were susceptible to heparin-mediated inhibition
of infection of NIH 3T3 cells. To investigate the interaction between the envelope glycoprotein (Env) of MLV
and heparin, we prepared vesicular stomatitis virus-based pseudotyped viruses carrying the Env of F-, A8, or
PVC-211MLVs. Surface plasmon resonance analyses indicated that the Env of A8 and PVC-211MLVs had a higher
binding activity to heparin than that of F-MLV. We examined the inﬂuence of N- or O-sulfation of heparin on
binding activity to Env and on the inhibition of the infectivity of MLV and pseudotyped viruses carrying Env.
This analysis indicated that the O-sulfate groups of heparin play a major role in determining Env-dependent in-
hibitory effects.
© 2011 Elsevier Inc. All rights reserved.Introduction
Previous studies have shown that soluble glycosaminoglycans
(GAGs), such as heparin, inhibit the infectivity of ecotropic murine
leukemia virus (MLV) (Batra et al., 1997; Guibinga et al., 2002;
Jinno-Oue et al., 2001; Le Doux et al., 1996, 1999; Masuda et al.,
1997; Walker et al., 2002). Jinno-Oue et al. (2001) found that hepa-
rin inﬂuences Env-dependent attachment of the virus to the cell sur-
face. By contrast, Walker et al. (2002) and Guibinga et al. (2002)
reported that heparin inhibits Env-independent interaction of MLV
with target molecules on the cell surface. Infection by ecotropic
MLV is mediated by the binding of the viral Env protein to the rodent
ortholog of cationic amino acid transporter 1 (CAT-1), which serves
as the speciﬁc cellular receptor (Albritton et al., 1989; Kim et al.,
1991; Wang et al., 1991). Although the Env-receptor interaction ap-
pears to be required for membrane fusion and entry of the viral cap-
sid, it has been reported that initial attachment of a retroviral
particle to the cell surface can take place in a receptor-
independent manner (Guibinga et al., 2002; Pizzato et al., 1999;
Walker et al., 2002). The fact that soluble GAGs, such as heparin, in-
hibit MLV infectivity suggests that cell surface GAGs, such as.
rights reserved.heparan sulfate, might be involved in the initial attachment (Batra
et al., 1997; Guibinga et al., 2002; Jinno-Oue et al., 2001; Le Doux
et al., 1996, 1999;Masuda et al., 1997;Walker et al., 2002). Similarly,
it has been shown that infection by other enveloped viruses, such as
herpes viruses (Neyts et al., 1992; Secchiero et al., 1997; WuDunn
and Spear, 1989), respiratory syncytial virus (Krusat and Streckert,
1997) and human immunodeﬁciency virus (HIV) (Mondor et al.,
1998; Patel et al., 1993), are inhibited by heparin, and that cell sur-
face attachment of these viruses involves cell surface GAGs. Thus,
the interaction of viral particles with soluble and cell surface GAGs
is an important issue for virology in general.
In the present study, we initially investigated the inﬂuence of heparin
on infection of ecotropic MLVs including Friend MLV (F-MLV) clone 57
(Oliff et al., 1980) and its neuropathogenic variants, A8 MLV (Takase-
Yoden and Watanabe, 1997; Watanabe and Takase-Yoden, 1995) and
PVC-211 MLV (Kai and Furuta, 1984; Masuda et al., 1992). The infection
of neonatal rats with A8 or PVC-211 MLV induces spongiform neurode-
generation without inﬂammatory inﬁltrates. The primary determinant
for neuropathogenicity of these viruses has been identiﬁed as Env. Com-
parison of the amino acid sequences of A8-Env andPVC-211-Env showed
that only 3 of the 676 amino acids differ. F-MLV is non-neuropathogenic
and F-Env shows differences at 26 of the 676 amino acids compared to
A8-Env. Here, we performed surface plasmon resonance (SPR) analyses
to compare the binding activities to heparin of pseudotyped viral parti-
cles carrying Env of ecotropic MLVs. To our knowledge, this is the ﬁrst
time that SPR technology has been applied in a quantitative analysis of
57Y. Seki et al. / Virology 424 (2012) 56–66the interaction between viral particles carrying MLV Env and heparin.
Heparin is a linear polysaccharide composed ofα1-4 linked disaccharide
repeating units. The most common unit contains 2-O-sulfated iduronic
acid and 6-O-sulfated, N-sulfated glucosamine. The negatively-charged
sulfate groups of heparan sulfate (which is structurally related to hepa-
rin) are thought to play an important role in its biological activity, such
asﬁbroblast growth factor (FGF) signaling, and to act as an entry receptor
for herpes simplex virus type 1 (Capila and Linhardt, 2002; Copeland et
al., 2008; Shukla et al., 1999; Xia et al., 2002; Ye et al., 2001). We also ex-
amined the relative importance of N- or O-sulfation of heparin for its in-
hibitory effects on infection by ecotropic MLVs and on the binding
activities to viral particles using chemically modiﬁed heparins: N-
acetylheparin (NA-H), which has diminished N-sulfation; de-N-sulfated
heparin (dNS-H), which completely lacks N-sulfation; and N-acetyl-de-
O-sulfated heparin (NAdOS-H), which has markedly diminished N-
sulfation and completely lacks O-sulfation. Taken together, the present
investigations have characterized the inhibitory activities of heparin
against ecotropic MLV infection of NIH 3T3 cells, while the SPR analysis
showed that the binding activity of ecotropic MLV with heparin may be
determined by Env amino acid sequences. We also demonstrate that
the O-sulfate groups of heparin play a major role in inhibiting the infec-
tivity of ecotropic MLV on cells in an Env-dependentmanner. The possi-
ble mechanisms of the inhibition of heparin against viral infection
and the implications of heparan sulfate on the cell surface are
discussed.Results
Inhibition of ecotropic MLV infection by heparin and its derivatives
We compared the effects of heparin and its derivatives on the in-
fectivity of F-, A8, and PVC-211 MLVs using viruses that had been pre-
incubated with various concentrations of heparin, or one of the deriv-
atives, in the absence of polybrene. After this pre-incubation step, the
virus-heparin or virus-derivative mixture was inoculated onto NIH
3T3 cells at a multiplicity of infection (MOI) of 1 in the presence of
10 μg/ml polybrene. We used polybrene for viral infection, because
MLV infections are usually carried out in the presence of polybrene
to enhance infection. After 72 h, viral production was evaluated by
measuring virion-associated reverse transcriptase (RT) activities in
the culture supernatants.
Pre-incubation of the viruses with heparin at concentrations
greater than 1 μg/ml resulted in a dose-dependent decrease in viral
production (Fig. 1A). The 50% inhibitory dose (ID50) values of heparin
for F-, A8, and PVC-211 MLVs were 12.7±4.5, 8.5±0.9, and
13.0±3.3 μg/ml, respectively; these values were not signiﬁcantly dif-
ferent (Table 1). The structure of the most common disaccharide unit
of heparin is composed of 2-O-sulfated iduronic acid and 6-O-sulfat-
ed, N-sulfated glucosamine (Fig. 1E). To investigate whether differ-
ences in the sulfation patterns of heparin affect the ability to inhibit
ecotropic MLV infection, we pre-incubated viruses with a heparin de-
rivative: NAdOS-H, which has markedly diminished N-sulfation and
no O-sulfation; NA-H, which has diminished N-sulfation; or dNS-H,
which completely lacks N-sulfation. NAdOS-H did not show inhibito-
ry effects on infection of NIH 3T3 cells with F-, A8, or PVC-211 MLV
even at a concentration of 1000 μg/ml (Fig. 1B and Table 1). In con-
trast, NA-H inhibited production of F-, A8, and PVC-211 MLVs in
infected NIH 3T3 cells, with ID50 values of 54.5±4.1, 62.1±2.5,
and 53.7±2.8 μg/ml, respectively (Fig. 1C and Table 1); these
values were signiﬁcantly higher than for heparin (Pb0.001).
dNS-H also inhibited infection of NIH 3T3 cells with F-, A8, and
PVC-211 MLVs, with ID50 values of 76.8±3.9, 65.4±2.3, and
72.4±4.2 μg/ml, respectively (Fig. 1D and Table 1). The ID50
values for dNS-H were signiﬁcantly higher than those of heparin
(Pb0.001).Preparation of vesicular stomatitis virus (VSV)-based pseudotyped viruses
carrying ecotropic MLV Env
Previous studies suggested that heparin affects ecotropicMLV infec-
tion during the early steps of viral replication.We used pseudotyped vi-
ruses bearing Env to analyze the effects of heparin on the viral
replication process from the attachment to gene expression steps. We
also sought to clarify the contribution of Env of ecotropic MLV to the in-
hibitory effects of heparin against viral infectivity by examining this re-
sponse in the absence of other retroviral proteins, such as Gag and Pol,
that might inﬂuence heparin-mediated reduction in infectivity. To this
end, we prepared VSV based-pseudotyped viruses carrying the Env of
F-, A8, or PVC-211 MLV (VSV/F-Env, VSV/A8-Env, and VSV/PVC-211-
Env, respectively) using 293T cells.
Initially, we performed aWestern blot analysis using an anti-Env an-
tibody to examine whether Env protein is normally expressed in the
293T cells transfectedwith F-, A8-, and PVC-211-Env expression vectors,
and compared the expression levels of Env in these cells. In the trans-
fected 293T cells, the primary product observed was gp70, although
gpr85 was also detectable (lanes 1–3 in Fig. 2). The expression levels
of Env protein were similar in cells transfected with F-, A8-, and PVC-
211-Env expression vectors. The Env-expressing cells were infected
with recombinant VSV, which has the green ﬂuorescence protein
(GFP) gene in place of the viral G protein gene, andVSV-pseudotyped vi-
ruses carring Env were obtained. As a control, VSV viruses-like particles
lacking Env (VSV/ΔEnv) were also obtained as described in the
Materials and methods section. Next, we compared the amount of Env
protein packaged in VSV-pseudotyped viruses among VSV/F-Env, VSV/
A8-Env, and VSV/PVC-211-Env. In total, 2×105 infectious units of VSV/
F-Env, VSV/A8-Env, and VSV/PVC-211-Env were spun down and the
precipitates were used in a Western blot analysis. With regard to viral
particles, gp70 was observed, and the amount of Env protein showed
no appreciable differences among the virions (lanes 5–7 in Fig. 2).
Inhibitory effects of heparin and its derivatives on the infectivity of VSV-
based pseudotyped viruses carrying ecotropic MLV Env
We examined the inhibitory effects of heparin and its derivatives on
the infectivity of VSV-based pseudotyped viruses carrying ecotropic
MLV Env. VSV/F-Env, VSV/A8-Env, and VSV/PVC-211-Env were pre-
incubated with various concentrations of heparin, or a derivative, in
the absence of polybrene, and then inoculated onto NIH 3T3 cells at
an MOI of 1 in the presence of 10 μg/ml polybrene. After 16 h, GFP-
positive cells were counted by ﬂuorescence-activated cell sorting
(FACS) in order to evaluate viral infectivity. Heparinwas found to inhib-
it infection of NIH 3T3 cells with VSV/F-Env, VSV/A8-Env, and VSV/PVC-
211-Env (Fig. 3A) with ID50 values of 7.0±0.3, 8.0±0.3, and
7.4±0.4 μg/ml, respectively (Table 2). Although NAdOS-H did not in-
hibit infectivity of VSV/F-Env, VSV/A8-Env, or VSV/PVC-211-Env on
NIH 3T3 cells (Fig. 3B and Table 2), high concentrations of NA-H or
dNS-H did show inhibition of infection of NIH 3T3 cells (Figs. 3C and
D). The ID50 values of NA-H (50.1±3.9, 53.4±2.6, and 50.8±3.7 μg/
ml for VSV/F-Env, VSV/A8-Env, and VSV/PVC-211-Env, respectively)
and of dNS-H (67.8±1.5, 64.8±2.0, and 71.5±1.8 μg/ml for VSV/F-
Env, VSV/A8-Env, and VSV/PVC-211-Env, respectively) were signiﬁ-
cantly higher than those of heparin (Pb0.001) (Table 2).
We also sought to compare the effects of heparin and its derivatives on
the infectivity ofΔEnv-VSV-pseudotyped viruses. However, the efﬁciency
of GFP gene transduction of the cells with theΔEnv-VSV-pseudotyped vi-
ruses was too low to allow a reliable comparison to be carried out.
SPR analysis of the direct interactions of ecotropic MLV Env with heparin
or its derivatives
In order to analyze direct interactions between Env and heparin,
we measured the binding activities of VSV/F-Env, VSV/A8-Env, and
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Fig. 1. Inhibitory activities of heparin and three derivatives against production of retroviruses in NIH 3T3 cells. F- (triangle), A8 (circle), and PVC-211 (square) MLVs were pre-
incubated with various concentrations of heparin (A), NAdOS-H (N-acetyl-de-O-sulfated heparin) (B), NA-H (N-acetylheparin) (C), or dNS-H (de-N-sulfated heparin) (D) for 1 h
at 37 °C in the absence of polybrene. The virus–heparin mixture was then inoculated onto NIH 3T3 cells in the presence of 10 μg/ml polybrene. After incubation for 1 h at 37 °C,
the cells were washed three times with FCS-free DMEM and fresh culture medium was added. After 72 h, virion-associated RT activity in the culture supernatants was measured
by an RT assay as described in the Materials and methods section. The mean values of 4 independent experiments and SEM are shown. (E) Schematic diagram of the major disac-
charide repeating units of heparin. The most common disaccharide unit of heparin is composed of 2-O-sulfated iduronic acid and 6-O-sulfated, N-sulfated glucosamine.
58 Y. Seki et al. / Virology 424 (2012) 56–66VSV/PVC-211-Env to a heparin-immobilized chip (Heparin chip) by
SPR. The SPR analyses were performed in the absence of polybrene;
this protocol was adopted because in the experiments on inhibition
of viral infection by heparin (Figs. 1 and 3), the viruses were pre-
incubated with heparin in the absence of polybrene. Two different
preparations of each pseudotyped virus were used for the analysis.Table 1
ID50 of heparin and three derivatives against infection of MLVs into NIH 3T3 cells.
Reagents Viruses
F A8 PVC-211
Heparin 12.7±4.5a 8.5±0.9a 13.0±3.3a
NAdOS-H >1000 >1000 >1000
NA-H 54.5±4.1 62.1±2.5 53.7±2.8
dNS-H 76.8±3.9 65.4±2.3 72.4±4.2
ID50 values (μg/ml) were calculated from the data shown in Fig. 1. The mean values
(and SEMs) of 4 independent experiments are shown. Statistical comparison was
performed using the t test. NAdOS-H: N-acetyl-de-O-sulfated heparin; NA-H:N-acetyl-
heparin; dNS-H: de-N-sulfated heparin.
a Pb0.001 vs NA-H and dNS-H in each virus.Env-deﬁcient VSV-like particles (VSV/ΔEnv) and culture supernatant
from 293T cells (Mock) were used as negative controls. Typical sen-
sorgrams of the binding of the samples to the Heparin chip are
shown in the top column of Fig. 4A. The ﬂow of the viral particles,
at various concentrations, across the Heparin chip was started at 0 s,
and ﬂow of the washing buffer was started at 300 s. Since the binding
of virus to the Heparin chip appeared to reach equilibrium at 450 s,
the Δdeg value at 450 s was selected as reﬂecting binding activity
and plotted as shown in the top column of Fig. 4B. The results indicat-
ed that VSV-based pseudotyped viruses were bound to the Heparin
chip in a dose-dependent manner. The binding activities of VSV/A8-
Env and VSV/PVC-211-Env were clearly higher than that of VSV/F-
Env, which exhibited higher binding activity than the negative con-
trols. When viruses were saturated with heparin prior to SPR
analysis, binding to the Heparin chip was inhibited (data not
shown).
The binding activities of the VSV-based pseudotyped viruses to
NAdOS-H or dNS-H immobilized on SPR sensor chips (NAdOS-H or
dNS-H chips, respectively) were also examined (middle and bottom
columns of Figs. 4A and B). We found that VSV-based pseudotyped
viruses showed dose-dependent binding to the NAdOS-H or dNS-
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Fig. 2. Western blot analysis of the expression levels of Env in 293T cells transfected with Env expression vectors and VSV-pseudotyped virus particles. Lanes 1–3: 293T cells transfected
with Env expression vectors. Lane 4: Mock-transfected 293T cells. Lanes 5–7: VSV-pseudotyped virus particles carring Env. 2×105 infectious units of viruses were applied to theWestern
blot. Details are given in theMaterials andmethods section. Lane 8: Env-deﬁcient VSV-like particles prepared as described in theMaterials andmethods section. Lane 9: culture supernatant
from 293T cells (used in the SPR analysis as a Mock control) was prepared as described in theMaterials andmethods section. To detect the Env protein, anti-SU (gp70) was used. Relative
amount of Env protein is shown in parentheses. The expression levels of Env protein of transfected 293T cells were normalized against the intensity of the beta-actin band and are shown
relative to the cell transfected with F-Env expression vector. The amount of Env protein in virions is shown relative to the VSV/F-Env. This ﬁgure is representative of repeat experiments.
Experiments with each sample were performed twice and similar results were obtained.
59Y. Seki et al. / Virology 424 (2012) 56–66H chips. The binding activities of VSV/A8-Env and VSV/PVC-211-
Env to NAdOS-H or dNS-H were higher than those of VSV/F-Env.
The binding activities of VSV/A8-Env and VSV/PVC-211-Env to
NAdOS-H were clearly lower than those to heparin, but were simi-
lar or slightly lower than those to dNS-H. The binding activities of
VSV/F-Env to NAdOS-H were slightly lower than those to heparin,0
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Table 2
ID50 of heparin and three derivatives against infection of VSV based-pseudotyped vi-
ruses carrying Env of MLV into NIH 3T3 cells.
Reagents VSV based-pseudotyped viruses
VSV/F-Env VSV/A8-Env VSV/PVC-211-Env
Heparin 7.0±0.3a 8.0±0.3a 7.4±0.4a
NAdOS-H >1000 >1000 >1000
NA-H 50.1±3.9 53.4±2.6 50.8±3.7
dNS-H 67.8±1.5 64.8±2.0 71.5±1.8
ID50 values (μg/ml) were calculated from the data shown in Fig. 3. The mean values
(and SEMs) of 4 independent experiments are shown. Statistical comparison was
performed using the t test. NAdOS-H: N-acetyl-de-O-sulfated heparin; NA-H:N-acetyl-
heparin; dNS-H: de-N-sulfated heparin.
a Pb0.001 vs NA-H and dNS-H in each virus.
60 Y. Seki et al. / Virology 424 (2012) 56–66Effect of polybrene on heparin-induced inhibition of MLV infection
In order to determine the effect of polybrene on the inhibitory ac-
tivity of heparin against MLV infection, we performed experiments in
the presence and absence of polybrene. Firstly, we examined the ef-
fects of polybrene on MLV infection at an MOI of 1. In the absence of
polybrene, at 72 h post-infection, viral production of MLVs was unde-
tectable level by an RT assay; at 96 h post-infection, viral production
was detectable but was 10- to 50-fold lower than in the presence of
polybrene (data not shown). In the presence of polybrene, viral produc-
tion at 96 h post-infection was higher than at 72 h post-infection.
Therefore, we evaluated viral production at 96 h post-infection in the
following experiment. F-, A8, and PVC-211 MLVs were pre-incubated
with various concentrations of heparin in the absence of polybrene,
and then inoculated onto NIH 3T3 cells at anMOI of 1 either in the pres-
ence of 10 μg/ml polybrene or in its absence; viral productionwas eval-
uated at 96 h. In the presence of polybrene, the ID50 values of heparin
for F-, A8, and PVC-211 MLVs were 44.4±6.7, 47.9±0.8, and 49.6
±2.2 μg/ml, respectively; these values were not signiﬁcantly different
(Fig. 5A and Table 3). The ID50 values in this experiment are higher
than those shown in Fig. 1A and Table 1 due to differences in culture
time; nevertheless, the inhibition curves in Fig. 5A are similar to those
in Fig. 1A. In the absence of polybrene, the ID50 values of heparin for
F-, A8, and PVC-211 MLVs were 0.56±0.08, 0.61±0.10, and 0.60±
0.05 μg/ml, respectively (Fig. 5B and Table 3); these values are not sig-
niﬁcantly different. However, these values are signiﬁcantly lower than
those in the presence of polybrene (Pb0.001).
We also attempted to examine the effects of polybrene on the inhib-
itory activity of heparin against infection of NIH 3T3 cells by VSV-
pseudotyped viruses. However, the efﬁciency of GFP gene transduction
of the cells with the pseudotyped viruses in the absence of polybrene
was too low to allow the effects of heparin to be reliably compared
(data not shown).
Discussion
Soluble GAGs, such as heparin, have been shown to inhibit infec-
tion by MLV (Guibinga et al., 2002; Jinno-Oue et al., 2001; Walker et
al., 2002). It has been reported that this inhibitory effect is deter-
mined by a number of factors: GAG concentration; electrostatic
charge on the GAG; the afﬁnity of the virus to the GAG; the cells
from which the viruses are produced; and the cell type infected
with the viruses. In this study, we examined the effects of soluble
GAGs on the ability of ecotropic MLVs produced by NIH 3T3 cells to
infect NIH 3T3 cells. Jinno-Oue et al. (2001) showed that, in the ab-
sence of polybrene, low concentrations of heparin (up to 100 μg/ml)
enhanced the infectivity of F- and PVC-211 MLVs, whereas higher
concentrations inhibited infectivity. In contrast, we found that
0.1 μg/ml of heparin did not affect the infectivity of F-, A8, and PVC-
211 MLVs in the absence of polybrene; however, concentrationsgreater than 1 μg/ml, heparin inhibited infectivity (Fig. 5B). In the
presence of polybrene, we found that 1 μg/ml or less of heparin did
not affect the infectivity of F-, A8, and PVC-211 MLVs; at concentra-
tions greater than 10 μg/ml, however, heparin inhibited infectivity
in a dose-dependent manner (Figs. 1A and 5A). The apparent lack of
any enhancing effects of heparin on ecotropic MLV infectivity in the
present study may be due to differences in experimental conditions.
Thus, the discrepant results in this and the previous study might be
a consequence of using different cell types in which to measure
viral infectivities. Jinno-Oue et al. (2001) used Rat-1 and primary rat
brain capillary endothelial cells (BCEC) as target cells, while we
used mouse NIH 3T3 cells.
Walker et al. (2002) and Guibinga et al. (2002) reported that the
cell surface attachment of Env-deﬁcient retrovirus-like particles was
inhibited by heparin, suggesting that heparin inhibits Env-
independent interaction of MLV with target molecules on the cell sur-
face. By contrast, Jinno-Oue et al. (2001) showed that subtle changes
in the Env protein amino acid sequences, which generated a heparin-
binding site(s), could affect the heparin-binding afﬁnity of the viruses
and the susceptibility of the viruses to the effects of heparin. Thus, it is
likely that heparin inﬂuences not only Env-independent attachment,
but also Env-dependent attachment of the virus to the cell surface.
In our present study, the binding to heparin by VSV-based pseudo-
typed viruses carrying the Env of F-, A8, or PVC-211 MLVs was quan-
titatively examined by SPR analysis. To our knowledge, the present
study is the ﬁrst to quantitatively compare heparin binding activities
of Env of different ecotropic MLVs using SPR technology. Our results
indicated that the binding activities of VSV based-pseudotyped virus-
es carrying the Env of ecotropic MLVs were higher than that of the
Env-deﬁcient virus-like particle, and that the Env sequence inﬂu-
enced the binding activity of the pseudotyped viruses to heparin
(Figs. 4 and 6). Therefore, the results strongly suggest that the Env
per se of these ecotropic MLVs can directly interact with heparin.
PVC-211-Env exhibited the highest heparin binding activity, followed
by A8-Env, and then F-Env (Fig. 4). These results are consistent with
those of a previous study in which heparin agarose was used to assess
the heparin binding activities of F-MLV and PVC-211 MLV (Jinno-Oue
et al., 2001). F-Env, which showed the lowest binding activity to hep-
arin, had 26 amino acid substitutions compared to A8-Env (Fig. 6). By
contrast, A8-Env and PVC-211-Env showed similar binding activities
and differed by only 3 amino acids (Fig. 6). The consensus sequences
for the heparin-binding domain (HBD) are XBBXBX and XBBBXXBX,
where X represents any amino acid and B indicates a basic amino
acid (Cardin and Weintraub, 1989). A stretch of 6 amino acids from
Ser124 to Glu129 in the receptor-binding domain (RBD) of F-Env con-
stitutes a putative HBD. However, a previous study suggested that
this sequence did not function as an HBD (Jinno-Oue et al., 2001).
Compared to F-Env, the substitution of Glu129 by Lys in PVC-211-
Env generated an additional, overlapping HBD from Pro127 to Ser132.
This new HBD has been suggested to contribute to the high binding
ability of PVC-211 MLV for heparin. Intriguingly, the amino acids at
positions 124 to 132 of A8-Env are identical to those of F-Env, and
thus A8-Env has only one putative HBD that might not be functional.
Therefore, the number of HBDs cannot explain the difference in bind-
ing activities of A8-Env and F-Env to heparin. Recently, the heparin
binding activities of wild-type and mutant gp120 of HIV-1 were stud-
ied using SPR-based binding assays (Crublet et al., 2008). Four new
HBDs were identiﬁed in the V2 and V3 loops, in the C-terminal do-
main, and within the CD4-induced bridging sheet. Three of these
HBDs were found in domains of the protein that are involved in co-
receptor recognition. In particular, Arg419, Lys421, and Lys432, which
directly interact with the co-receptor, are targeted by heparin, sug-
gesting that these basic amino acids are important for the interaction
with heparin. In contrast to F-Env, which has Gln61 and Ser80 in the
variable region A (VRA) of RBD, both A8-Env and PVC-211-Env have
Arg61 and Arg80 in common (Fig. 6). Therefore, we suggest that
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Fig. 4. SPR analysis of the binding of VSV based-pseudotyped viruses carrying Env of F- (VSV/F-Env), A8 (VSV/A8-Env), or PVC-211 MLV (VSV/PVC-211-Env) to heparin, NAdOS-H
(N-acetyl-de-O-sulfated heparin), or dNS-H (de-N-sulfated heparin) immobilized on SPR sensor chips. Two independent preparations (Prep. 1 and Prep. 2) of VSV/F-Env, VSV/A8-
Env, and VSV/PVC-211-Env were tested. (A) SPR sensorgrams of viral particles of Prep. 1 for the Heparin chip, the NAdOS-H chip, or the dNS-H chip. (B) The equilibrium level of
binding of viral particles to the Heparin chip, the NAdOS-H chip, or the dNS-H chip at 450 s. VSV/ΔEnv: Env-deﬁcient VSV-like particles; Mock: culture supernatants of 293T cells.
1×106 infectious units of VSV based-pseudotyped viruses carrying Env were prepared and treated for SPR analysis as described in the Materials and methods section. VSV/ΔEnv and
Mock controls were prepared as described in the Materials and methods section. The aliquots from both controls were equivalent in volume to those from the culture supernatants
of VSV/Env-producing cells, which contained 1×106 infectious units, and were treated in the same manner.
61Y. Seki et al. / Virology 424 (2012) 56–66these two residues in A8- and PVC-211-Env might contribute to the
higher heparin-binding activity. Furthermore, Lys129 is present only
in PVC-211-Env and may be responsible for the additional heparin-
binding activity.
Although PVC-211-Env had the highest heparin binding activity,
followed by A8-Env, and then F-Env (Fig. 4), the ID50 values of hep-
arin for infection by PVC-211, A8, or F-MLV were not signiﬁcantly
different (Fig. 1 and Table 1). Similarly, the ID50 values of heparin
for infection of VSV-based pseudotyped viruses bearing PVC-211-,
A8-, or F-Env were not signiﬁcantly different (Fig. 3 and Table 2).
The reasons why the estimates for inhibition of viral infection donot correlate with those from the SPR analyses are not clear, but
the following possibilities could be suggested. First, the relatively
low binding activity of Env to heparin, which was observed in the
SPR analysis of F-Env, might be sufﬁcient to block viral infection.
Second, the SPR analysis might be more sensitive to heparin-
binding activity than the inhibition assay of viral infectivity. In the
SPR analysis, viral particles bind to heparin immobilized to a chip,
and then excess and low-afﬁnity viral particles are washed out. In
contrast, in the inhibition assay, small soluble molecules of heparin
bind to the Env of viruses, and thus relatively low-afﬁnity binding
between heparin and Env could have a signiﬁcant effect on viral
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62 Y. Seki et al. / Virology 424 (2012) 56–66infection. Third, we cannot exclude the possibility that heparin
might affect viral replication steps except for attachment. Although
we used VSV-pseudotyped viruses carrying Env for the inhibition
assay against viral infection, the assay did not distinguish rigorously
between viral attachment and alternative steps in infection, such as
entry and gene expression. Therefore, heparin might not only inﬂu-
ence viral attachment but also entry and gene expression, with the
result that the ID50 values for viral infection are similar among the
viruses despite the fact that they carry different Envs.
Heparin is a highly sulfated polysaccharide with a negative charge
and its most common disaccharide unit is composed of 2-O-sulfated
iduronic acid and 6-O-sulfated, N-sulfated glucosamine (Fig. 1E). Sul-
fation of heparan sulfate, which is structurally related to heparin, is
thought to play an important role in its biological activity such as
FGF signaling and its ability to act as an entry receptor for herpes sim-
plex virus type 1 (Capila and Linhardt, 2002; Copeland et al., 2008;
Shukla et al., 1999; Xia et al., 2002; Ye et al., 2001). It has also been
shown that the chemical structure of the carbohydrate unit constitut-
ing the GAG backbone is an important determinant for the ability of
the GAG to inhibit retroviral infection (Jinno-Oue et al., 2001;
Walker et al., 2002). By comparing the effects of heparin and dNS-H,
Jinno-Oue et al. (2001) concluded that N-sulfation of GAG is impor-
tant for the effects on infectivity of ecotropic MLVs. In this study,
NA-H, which has diminished N-sulfation, and dNS-H, which
completely lacks N-sulfation, were shown to be less effective than
heparin in inhibiting infection of NIH 3T3 cells by pseudotyped virus-
es carrying ecotropic MLV Env (Fig. 3 and Table 2). We have, there-
fore, conﬁrmed that N-sulfation of GAG plays an important role in
the inhibition of ecotropic MLV infection. In addition, NAdOS-H,
which has markedly diminished N-sulfation and completely lacks O-
sulfation, did not signiﬁcantly alter infectivity of pseudotyped viruses
on NIH 3T3 cells (Fig. 3). Comparison of dNS-H and NAdOS-H strongly
suggests that the O-sulfate groups of GAG are also required for the in-
hibitory effects on MLV infection. Intriguingly, the results of the SPRTable 3
ID50 of heparin against infection of MLVs into NIH 3T3 cells in the presence or absence
of polybrene.
Polybrene Viruses
F A8 PVC-211
Present 44.4±6.7 47.9±0.8 49.6±2.2
Absent 0.56±0.08a 0.61±0.10a 0.60±0.05a
ID50 values (μg/ml) were calculated from the data shown in Fig. 5. The mean values
(and SEMs) of 4 independent experiments are shown. Statistical comparison was
performed using the t test.
a P b0.001 vs presence of polybrene in each virus.analysis indicated that NAdOS-H, which failed to inhibit ecotropic
MLV infection, binds to F-, A8-, and PVC-211-Env at levels comparable
to those of dNS-H, which unequivocally exhibited inhibitory effects
on viral infection. Therefore, binding of GAG to the viral Env may be
essential, but not sufﬁcient, for inhibition of Env-dependent MLV at-
tachment to the cell surface. Previous studies have highlighted the
importance of the O-sulfate group of heparin for its inhibitory activi-
ties against infection by pseudorabies virus (Trybala et al., 1996), her-
pes simplex virus (Trybala et al., 2000), and HIV (Rider et al., 1994). In
contrast, N-sulfation of heparin is required for inhibition of respirato-
ry syncytial virus infection (Hallak et al., 2000). The results from theAsp
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Fig. 6. Amino acid sequences of F-, A8-, and PVC-211-Env. A schematic diagram of the
Env precursor polyprotein is shown at the bottom. SS: signal sequence; SU: surface
protein; TM: transmembrane protein; RBD: receptor-binding domain (Fass et al.,
1997); VRA: variable region A; VRB: variable region B; VRC: variable region C. The
N-terminal amino acid of the SU is numbered as 1.
63Y. Seki et al. / Virology 424 (2012) 56–66earlier studies and from here suggest that different types of sulfate
groups are required for the inhibitory activities of heparin against dif-
ferent viruses, and that the anti-viral activity of heparin does not de-
pend simply on negative charge density but involves particular
structures, notably sulfation patterns.
Although the interaction between Env and CAT-1, the receptor
molecule for MLV, appears to be required for membrane fusion and
entry of the viral capsid, it has been reported that initial attachment
of MLV to the cell surface can take place in a receptor-independentA
Polybrene: —
HBDHBD
B
Polybrene: +
C
Polybrene: +
HBDHBD
CATVirus HSPG
Fig. 7. Schematic diagrams of possible mechanisms of attachment of MLV to cells and of the i
the Discussion section. CAT-1: cationic amino acid transporter 1 as the speciﬁc receptor formanner (Guibinga et al., 2002; Pizzato et al., 1999; Walker et al.,
2002). Heparan sulfate on the cell surface was proposed as a candi-
date cell surface molecule for MLV attachment (Batra et al., 1997;
Guibinga et al., 2002; Jinno-Oue et al., 2001; Le Doux et al., 1996,
1999; Masuda et al., 1997; Walker et al., 2002). The SPR analyses car-
ried out in the present study also suggest that heparan sulfate on the
cell surface is involved in MLV attachment as we found that heparin
could bind directly to the Env of MLV. The exact role(s) of the cell sur-
face heparan sulfate in MLV infection is still unknown; nevertheless,D
Polybrene: —, Heparin: +
(1)
(2)
Polybrene: + , Heparin: + 
E
Polybrene: + , Heparin: + 
(1)(2)
F
-1 Polybrene Heparin
(3)
nhibition of attachment by heparin. These various possibilities are described in detail in
ecotropic MLV; HSPG: heparan sulfate proteoglycan.
64 Y. Seki et al. / Virology 424 (2012) 56–66we suggest a possible model for its behavior in Fig. 7. In this model,
heparan sulfate on the cell surface is envisaged as a route for viral in-
fection. The viral particles ﬁrst bind to heparan sulfate via the HBD of
Env and the increase in concentration of viral particles on the cell sur-
face then raises the probability of interaction with CAT-1. On the cell
surface, CAT-1 is covered by long chains of heparan sulfate that have a
large net negative charge. In the absence of polybrene, it is difﬁcult for
viral particles with a negative charge to approach CAT-1 and/or
heparan sulfate on the cell surface due to electrostatic repulsion
(Fig. 7A). MLV infections are usually carried out in the presence of
cationic polymers, such as polybrene to enhance infection, because
the infectivity of MLV is very low in the absence of polybrene (Davis
et al., 2002). Polybrene appears to enhance the infectivity of MLVs
through various possible mechanisms, and some of these have been
identiﬁed in previous studies. Initially, the positive charge of poly-
brene might neutralize the negative charge on the cell surface, facili-
tating access of the viral particles to CAT-1 and/or heparan sulfate on
the cell surface (Fig. 7B) (Davis et al., 2004). A second possibility is
that polybrene might cause the viral particles to form aggregates
that have easier access to the cell surface (Fig. 7C) (Davis et al.,
2004; Landazuri and Le Doux, 2004). Based on these putative mecha-
nisms, how might heparin inhibit infection by ecotropic MLV? It is
possible that heparin binds to a region near the RBD of Env and steri-
cally or electrostatically blocks interaction between Env and CAT-1
(arrow (1) in Figs. 7D and E). A second possibility is that heparin
binds to HBD of Env and that viral particles covered with heparin can-
not bind to heparan sulfate on the cell surface (arrow (2) in Figs. 7D
and E). Alternatively, viral particles bearing heparin have a large net
negative charge and might fail to access the cell surface due to elec-
trostatic repulsion. A ﬁnal possibility is that polybrene might not be
able to aggregate heparin-covered viral particles that bear large neg-
ative charges, and this might make access to the cell surface less efﬁ-
cient (Fig. 7F). The ID50 values of heparin for F-, A8, and PVC-211
MLVs were lower in the absence of polybrene than in its presence
(Fig. 5 and Table 3). In the absence of polybrene, the negative charge
of cell surface molecules is not neutralized. Therefore, it is possible
that the repulsion between viral particles bearing heparin and cell
surface molecules with a negative charge is stronger in the absence
of polybrene than in its presence (Figs. 7D and E). As a result, heparin
is able to inhibit viral infection effectively in the absence of polybrene.
Alternatively, in the presence of polybrene, the part of the heparin
molecule that normally binds to viral particles might instead bind
with polybrene (arrow (3) in Fig. 7E), with the consequence that a
relatively large amount of heparin is required for inhibition of viral
infection.
Materials and methods
Reagents
Heparin (H4784), N-acetylheparin (A8036) (NA-H), de-N-sulfated
heparin (D4776) (dNS-H), and N-acetyl-de-O-sulfated heparin (A6039)
(NAdOS-H) were obtained from Sigma. Heparin obtained from Nacalai
Tesque was used in the SPR analysis.
Cells and viruses
NIH 3T3 cells were grown in Dulbecco's modiﬁed Eagle's medium
(DMEM) containing 10% fetal calf serum (FCS). Mus dunni cells were
grown in RPMI1640 medium containing 10% FCS. 293T cells were
grown on DMEM containing 5% FCS.
Infectious DNA clones of neuropathogenic A8 (Takase-Yoden and
Watanabe, 1997; Watanabe and Takase-Yoden, 1995) (database ID:
D88386) and PVC-211 MLVs (Kai and Furuta, 1984; Masuda et al.,
1992) (database ID: M93134.1) and non-neuropathogenic F-MLV
clone 57 (Oliff et al., 1980) (database ID: X02794) were describedpreviously. NIH 3T3 cells were transfected with each DNA clone,
and culture supernatants of the virus-producing cells were harvested
and stored at −80 °C as stock viruses. Virus titers were determined
by a focal immunoassay on Mus dunni cells in the presence of 10 μg/
ml polybrene as described previously (Czub et al., 1991).
Assay of viral reverse transcriptase
Culture supernatants of the virus-producing cells were centri-
fuged at 5000 rpm for 5 min at 4 °C. To disrupt the viral particles,
10 μl of the supernatant was mixed with 14 μl of an aqueous solution
of 7 mM Tris–HCl (pH7.6), 70 mM NaCl, 0.7 mM ethylenediaminete-
traacetic acid (EDTA), and 0.03% Triton X-100. The mixture was
then mixed with 16 μl of an aqueous solution of 125 mM Tris–HCl
(pH7.6), 150 mM NaCl, 25 mM dithiothreitol, 2.5 mM MnCl2,
250 μg/ml Poly(A) x (dT)15 (Roche Diagnostics), and 3H-TTP (1 μCi),
and incubated for 1 h at 37 °C (Robert-Guroff et al., 1977). The reac-
tion was stopped by addition of 1 μl 0.5 M EDTA, and incorporated ra-
dioactivity was determined as described previously (Tamura and
Takano, 1978).
VSV based-pseudotyped viruses
Recombinant VSV, VSVΔG*/GFP-G, was kindly provided by Dr.
Whitt. The virus carries the jellyﬁsh GFP gene in place of the viral G
protein gene, and its G protein is supplemented by a separate expres-
sion vector (Takada et al., 1997). The env genes of F-, A8, and PVC-211
MLVs were each cloned into a pCAGGS expression vector (pCAGGS-F-
env, pCAGGS-A8-env, and pCAGGS-PVC-211-env, respectively).
pCAGGS was kindly provided by Dr. Miyazaki, and transfected into
293T cells. To prepare VSV-based pseudotyped viruses, the cells
were infected 24 h after transfection with VSVΔG*/GFP-G at an MOI
of 10. After 12 h, the supernatant of each culture was replaced with
fresh medium, and the cells were cultured for an additional 12 h.
The culture supernatants were then collected, passed through a
0.22 μm pore size ﬁlter and stored at −80 °C as VSV-based pseudo-
typed viruses: VSV/F-Env, VSV/A8-Env, and VSV/PVC-211-Env, carry-
ing Env of F-, A8, and PVC-211 MLVs, respectively. 293T cells that had
not been transfected with the Env expression vector were also
infected with VSVΔG*/GFP-G for preparing VSV viruses-like particles
lacking Env (VSV/ΔEnv). To measure viral titer, NIH 3T3 cells were
infected with each of the pseudotyped viruses in the presence of
10 μg/ml of polybrene and, at 16 h post-infection, GFP-positive cells
were counted by ﬂow cytometry.
FACS analysis
Cells were harvested and washed twice with FACS buffer (phos-
phate-buffered saline [PBS] containing 0.25% FCS, 0.25% horse
serum, and 0.1% sodium azide). Then, the cells were suspended in
FACS buffer and analyzed for GFP expression using a FACSAria Cell
Sorter (BD Biosciences).
Immunoblot analysis
Western blot analysis was performed on 293T cells transfected
with pCAGGS-F-env, pCAGGS-A8-env, or pCAGGS-PVC-211-env vec-
tors, or with virions of VSV/F-Env, VSV/A8-Env, VSV/PVC-211-Env,
VSV/ΔEnv; Mock transfected cells were used as a control. Cells were
harvested at 48 h after transfection with the env expression vector.
Cells were washed with PBS and then lysed with 2% sodium dodecyl
sulfate (SDS) and 0.5 mM phenylmethylsulfonyl ﬂuoride (PMSF) in
PBS at 100 °C for 5 min. Nucleic acid was mechanically sheared
using a syringe with a 22-gauge needle. A 1 ml aliquot of each virus
supernatant, containing the 2×105 infectious units, was then sub-
jected to ultracentrifugation at 30,000 rpm in a Beckman SW 41 Ti
65Y. Seki et al. / Virology 424 (2012) 56–66rotor at 4 °C for 2 h to purify the virions. Precipitates containing vi-
rions were suspended in PBS. Sample buffer (5×) containing SDS,
DTT, glycerol, and bromophenol blue in Tris–HCl (pH 6.8) was
added to the cell lysate or the virion suspension. After boiling for
5 min, the lysates were loaded on a 10% SDS-polyacrylamide gel and
electrophoresed. The proteins were then transferred to an Immobilon
P membrane (Millipore) by electroblotting. To detect the Env protein,
goat anti-Rauscher MLV gp70 (Quality Biotech Incorporated-Resource
Laboratory) was used. Actin was detected using rabbit anti-beta-actin
(Santa Cruz Biotechnology) as a loading control. Horseradish
peroxidase-conjugated anti-goat IgG antibody and horseradish
peroxidase-conjugated anti-rabbit IgG antibody (Santa Cruz Biotech-
nology) were used as secondary antibodies. The membrane was de-
veloped with ECL plus reagents (GE Healthcare). Band images were
captured with LAS-3000 (FUJIFILM).Preparation of VSV based-pseudotyped viruses for SPR analysis
Suspensions of VSV/F-Env, VSV/A8-Env, or VSV/PVC-211-Env
(1×106 infectious units) were made up to 5 ml by adding fresh cul-
ture medium; they were then dialyzed in a cellulose tube (EIDIA
Co., Ltd.) against 200×PBS (v/v) for 24 h at 4 °C, with the outer solu-
tion refreshed four times. Then, the solutions were ﬁxed with 2%
paraformaldehyde (PFA) buffered with 0.12 M phosphate (pH7.3).
To remove the PFA, the solutions were dialyzed in a cellulose tube
against 200×PBS (v/v) for 24 h at 4 °C, with the outer solution
refreshed four times. Then, the solutions were concentrated at 4 °C
to 0.5 ml (2×106 infectious units/ml) using an Amicon Ultra-15
100 K Centrifugal Filter Device (Millipore) and stored at −80 °C
until use. For the negative control, we used an aliquot of the culture
supernatant of VSV/ΔEnv-producing 293T cells; for the Mock control,
we used an aliquot of the culture supernatant of 293T cells. For both
controls, the aliquot was equivalent in volume to the sample from
the culture supernatant of VSV/Env-producing cells, which contained
1×106 infectious units, and was treated in the samemanner as above.SPR analysis
Heparin, NAdOS-H and dNS-H were dialyzed against distilled
water using an MWCO3500 membrane (SpectroPore), lyophilized,
and then conjugated with an f-mono linker molecule to prepare the
ligand conjugate as previously described (Sato et al., 2009; Suda
et al., 2006). To prepare the Sugar Chip with immobilized ligand,
the surface of a gold-coated chip (SUDx-Biotec) was oxidatively
washed with UV ozone cleaner (Structure Probe Inc.) for 20 min
and then immersed in 1 μM of the ligand conjugate dissolved in
50% (v/v) methanol solution overnight at room temperature with
gentle agitation. The Sugar Chip was washed sequentially with
water, 0.05% Tween 20, and water and dried at room temperature.
For the SPR analysis, the Sugar Chip was set on a prism with refrac-
tion oil (nD=1.518, Cargill Laboratories Inc.) in an SPR apparatus
(SPR670M, Moritex). The SPR measurements were performed at
room temperature according to the manufacturer's instructions,
using PBS containing 0.05% Tween 20 as the running buffer at a
ﬂow rate of 15 μl/min.Acknowledgments
We thank Dr. M. A. Whitt for providing VSVΔG*/GFP-G, and Dr. J.
Miyazaki for providing pCAGGS. This work was supported in part by
funding from MEXT (Ministry of Education, Culture, Sports, Science
and Technology), the Matching Fund for Private Universities,
S0901015, 2009–2014.References
Albritton, L.M., Tseng, L., Scadden, D., Cunningham, J.M., 1989. A putativemurine ecotropic
retrovirus receptor gene encodes amultiplemembrane-spanning protein and confers
susceptibility to virus infection. Cell 57, 659–666.
Batra, R.K., Olsen, J.C., Hoganson, D.K., Caterson, B., Boucher, R.C., 1997. Retroviral gene
transfer is inhibited by chondroitin sulfate proteoglycans/glycosaminoglycans in
malignant pleural effusions. J. Biol. Chem. 272, 11736–11743.
Capila, I., Linhardt, R.J., 2002. Heparin–protein interactions. Angew. Chem. 41, 391–412.
Cardin, A.D., Weintraub, H.J., 1989. Molecular modeling of protein–glycosaminoglycan
interactions. Arteriosclerosis 9, 21–32.
Copeland, R., Balasubramaniam, A., Tiwari, V., Zhang, F., Bridges, A., Linhardt, R.J.,
Shukla, D., Liu, J., 2008. Using a 3-O-sulfated heparin octasaccharide to inhibit the
entry of herpes simplex virus type 1. Biochemistry 47, 5774–5783.
Crublet, E., Andrieu, J.P., Vives, R.R., Lortat-Jacob, H., 2008. The HIV-1 envelope glyco-
protein gp120 features four heparan sulfate binding domains, including the co-
receptor binding site. J. Biol. Chem. 283, 15193–15200.
Czub, M., Czub, S., McAtee, F.J., Portis, J.L., 1991. Age-dependent resistance to murine
retrovirus-induced spongiform neurodegeneration results from central nervous
system-speciﬁc restriction of virus replication. J. Virol. 65, 2539–2544.
Davis, H.E., Morgan, J.R., Yarmush, M.L., 2002. Polybrene increases retrovirus gene
transfer efﬁciency by enhancing receptor-independent virus adsorption on target
cell membranes. Biophys. Chem. 97, 159–172.
Davis, H.E., Rosinski, M., Morgan, J.R., Yarmush, M.L., 2004. Charged polymers modulate
retrovirus transduction via membrane charge neutralization and virus aggregation.
Biophys. J. 86, 1234–1242.
Fass, D., Davey, R.A., Hamson, C.A., Kim, P.S., Cunningham, J.M., Berger, J.M., 1997. Structure
of a murine leukemia virus receptor-binding glycoprotein at 2.0 angstrom resolution.
Science 277, 1662–1666.
Guibinga, G.H., Miyanohara, A., Esko, J.D., Friedmann, T., 2002. Cell surface heparan sul-
fate is a receptor for attachment of envelope protein-free retrovirus-like particles
and VSV-G pseudotyped MLV-derived retrovirus vectors to target cells. Mol.
Ther. 5, 538–546.
Hallak, L.K., Spillmann, D., Collins, P.L., Peeples, M.E., 2000. Glycosaminoglycan sulfation
requirements for respiratory syncytial virus infection. J. Virol. 74, 10508–10513.
Jinno-Oue, A., Oue, M., Ruscetti, S.K., 2001. A unique heparin-binding domain in the en-
velope protein of the neuropathogenic PVC-211 murine leukemia virus may con-
tribute to its brain capillary endothelial cell tropism. J. Virol. 75, 12439–12445.
Kai, K., Furuta, T., 1984. Isolation of paralysis-inducing murine leukemia viruses from
Friend virus passaged in rats. J. Virol. 50, 970–973.
Kim, J.W., Closs, E.I., Albritton, L.M., Cunningham, J.M., 1991. Transport of cationic
amino acids by the mouse ecotropic retrovirus receptor. Nature 352, 725–728.
Krusat, T., Streckert, H.J., 1997. Heparin-dependent attachment of respiratory syncytial
virus (RSV) to host cells. Arch. Virol. 142, 1247–1254.
Landazuri, N., Le Doux, J.M., 2004. Complexation of retroviruses with charged polymers
enhances gene transfer by increasing the rate that viruses are delivered to cells. J.
Gene Med. 6, 1304–1319.
Le Doux, J.M., Morgan, J.R., Snow, R.G., Yarmush, M.L., 1996. Proteoglycans secreted by
packaging cell lines inhibit retrovirus infection. J. Virol. 70, 6468–6473.
Le Doux, J.M., Morgan, J.R., Yarmush, M.L., 1999. Differential inhibition of retrovirus
transduction by proteoglycans and free glycosaminoglycans. Biotechnol. Prog. 15,
397–406.
Masuda, M., Remington, M.P., Hoffman, P.M., Ruscetti, S.K., 1992. Molecular charac-
terization of a neuropathogenic and nonerythroleukemogenic variant of Friend
murine leukemia virus PVC-211. J. Virol. 66, 2798–2806.
Masuda, M., Hanson, C.A., Dugger, N.V., Robbins, D.S., Wilt, S.G., Ruscetti, S.K., Hoffman,
P.M., 1997. Capillary endothelial cell tropism of PVC-211 murine leukemia virus
and its application for gene transduction. J. Virol. 71, 6168–6173.
Mondor, I., Ugolini, S., Sattentau, Q.J., 1998. Human immunodeﬁciency virus type 1
attachment to HeLa CD4 cells is CD4 independent and gp120 dependent and re-
quires cell surface heparans. J. Virol. 72, 3623–3634.
Neyts, J., Snoeck, R., Schols, D., Balzarini, J., Esko, J.D., Van Schepdael, A., De Clercq, E.,
1992. Sulfated polymers inhibit the interaction of human cytomegalovirus with
cell surface heparan sulfate. Virology 189, 48–58.
Oliff, A.I., Hager, G.L., Chang, E.H., Scolnick, E.M., Chan, H.W., Lowy, D.R., 1980. Transfec-
tion of molecularly cloned Friend murine leukemia virus DNA yields a highly leu-
kemogenic helper-independent type C virus. J. Virol. 33, 475–486.
Patel, M., Yanagishita, M., Roderiquez, G., Bou-Habib, D.C., Oravecz, T., Hascall, V.C.,
Norcross, M.A., 1993. Cell-surface heparan sulfate proteoglycan mediates HIV-1 in-
fection of T-cell lines. AIDS Res. Hum. Retroviruses 9, 167–174.
Pizzato, M., Marlow, S.A., Blair, E.D., Takeuchi, Y., 1999. Initial binding of murine leukemia
virus particles to cells does not require speciﬁc Env-receptor interaction. J. Virol. 73,
8599–8611.
Rider, C.C., Coombe, D.R., Harrop, H.A., Hounsell, E.F., Bauer, C., Feeney, J., Mulloy, B.,
Mahmood, N., Hay, A., Parish, C.R., 1994. Anti-HIV-1 activity of chemically modiﬁed
heparins: correlation between binding to the V3 loop of gp120 and inhibition of
cellular HIV-1 infection in vitro. Biochemistry 33, 6974–6980.
Robert-Guroff, M., Schrecker, A.W., Brinkman, B.J., Gallo, R.C., 1977. DNA polymerase
gamma of human lymphoblasts. Biochemistry 16, 2866–2873.
Sato, M., Ito, Y., Arima, N., Baba, M., Sobel, M., Wakao, M., Suda, Y., 2009. High-sensitivity
analysis of naturally occurring sugar chains, using a novel ﬂuorescent linkermolecule.
J. Biochem. 146, 33–41.
Secchiero, P., Sun, D., De Vico, A.L., Crowley, R.W., Reitz Jr., M.S., Zauli, G., Lusso, P.,
Gallo, R.C., 1997. Role of the extracellular domain of human herpesvirus 7 glyco-
protein B in virus binding to cell surface heparan sulfate proteoglycans. J. Virol.
71, 4571–4580.
66 Y. Seki et al. / Virology 424 (2012) 56–66Shukla, D., Liu, J., Blaiklock, P., Shworak, N.W., Bai, X., Esko, J.D., Cohen, G.H., Eisenberg,
R.J., Rosenberg, R.D., Spear, P.G., 1999. A novel role for 3-O-sulfated heparan sulfate
in herpes simplex virus 1 entry. Cell 99, 13–22.
Suda, Y., Arano, A., Fukui, Y., Koshida, S., Wakao, M., Nishimura, T., Kusumoto, S., Sobel, M.,
2006. Immobilization and clustering of structurally deﬁned oligosaccharides for sugar
chips: an improved method for surface plasmon resonance analysis of protein–
carbohydrate interactions. Bioconjug. Chem. 17, 1125–1135.
Takada, A., Robison, C., Goto, H., Sanchez, A., Murti, K.G., Whitt, M.A., Kawaoka, Y., 1997. A
system for functional analysis of Ebola virus glycoprotein. Proc. Natl. Acad. Sci. U. S. A.
94, 14764–14769.
Takase-Yoden, S., Watanabe, R., 1997. Unique sequence and lesional tropism of a new
variant of neuropathogenic Friend murine leukemia virus. Virology 233, 411–422.
Tamura, T.-A., Takano, T., 1978. A new, rapid procedure for the concentration of C-type
viruses from large quantities of culture media: ultraﬁltration by diaﬂo membrane
and puriﬁcation by ﬁcoll gradient centrifugation. J. Gen. Virol. 41, 135–141.
Trybala, E., Bergström, T., Spillmann, D., Svennerholm, B., Olofsson, S., Flynn, S.J., Ryan,
P., 1996. Mode of interaction between pseudorabies virus and heparan sulfate/
heparin. Virology 218, 35–42.Trybala, E., Liljeqvist, J.A., Svennerholm, B., Bergström, T., 2000. Herpes simplex virus types
1 and 2 differ in their interaction with heparan sulfate. J. Virol. 74, 9106–9114.
Walker, S.J., Pizzato, M., Takeuchi, Y., Devereux, S., 2002. Heparin binds to murine leu-
kemia virus and inhibits Env-independent attachment and infection. J. Virol. 76,
6909–6918.
Wang, H., Kavanaugh,M.P., North, R.A., Kabat, D., 1991. Cell-surface receptor for ecotropic
murine retroviruses is a basic amino-acid transporter. Nature 352, 729–731.
Watanabe, R., Takase-Yoden, S., 1995. Gene expression of neurotropic retrovirus in the
CNS. Prog. Brain Res. 105, 255–262.
WuDunn, D., Spear, P.G., 1989. Initial interaction of herpes simplex virus with cells is
binding to heparan sulfate. J. Virol. 63, 52–58.
Xia, G., Chen, J., Tiwari, V., Ju, W., Li, J.P., Malmstrom, A., Shukla, D., Liu, J., 2002.
Heparan sulfate 3-O-sulfotransferase isoform 5 generates both an
antithrombin-binding site and an entry receptor for herpes simplex virus,
type 1. J. Biol. Chem. 277, 37912–37919.
Ye, S., Luo, Y., Lu, W., Jones, R.B., Linhardt, R.J., Capila, I., Toida, T., Kan, M., Pelletier, H.,
McKeehan, W.L., 2001. Structural basis for interaction of FGF-1, FGF-2, and FGF-7
with different heparan sulfate motifs. Biochemistry 40, 14429–14439.
